Can’t be more proud! Great job! 💪🏽👏🏽
RT @paganolab: How D-type cyclins are degraded. https://t.co/4dXAukpUcC
RT @DanSimoneschi: Excited to share the results of my Ph.D. studies, now published @nature. Thank you to the amazing people that collaborat…
RT @paganolab: How D-type cyclins are degraded. https://t.co/4dXAukpUcC
Excited to share the results of my Ph.D. studies, now published @nature. Thank you to the amazing people that collaborated and supported me throughout all these years. Hopefully, our results will guide new therapeutic avenues against cancer. @nyulangone ht
Three cyclin D/cell cycle Nature papers on my birthday - thank you for this great gift @Nature, and congrats to all authors! https://t.co/AXKHrWFaOI https://t.co/7uwRAmJk7n https://t.co/a6oI6l2eHp
" Loss of AMBRA1 reduces sensitivity to CDK4/6 inhibitors by promoting the formation of complexes of D-type cyclins with CDK2. " https://t.co/Hm9bPPpwhv
How D-type cyclins are degraded. https://t.co/4dXAukpUcC
Excited to see hot of the press this beautiful collaborative study on post-translational of cyclins in cancer @nature @nyugrossman @DanSimoneschi https://t.co/VxQs3JMEef
CRL4AMBRA1 is a master regulator of D-type cyclins https://t.co/xkHloy6nES